Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05053945 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 years later Dec 1, 2025 → Dec 31, 2030
See other at-risk trials from Chinese University of Hong Kong

Record History

  1. Primary completion pushed from Dec 1, 2025 to Dec 31, 2030 Trial status changed: Unknown → Recruiting · Completion pushed from Dec 31, 2025 to Dec 31, 2030 · Eligibility criteria expanded, about 6 words Show 3 more changesShow less
    • Trial status changed: Unknown → Recruiting
    • Completion pushed from Dec 31, 2025 to Dec 31, 2030
    • Eligibility criteria expanded, about 6 words
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Trial status: Recruiting to Unknownv3
  4. Primary completion date: Feb 2, 2023 to Dec 1, 2025 Primary endpoint revised · Completion date: Mar 1, 2023 to Dec 31, 2025 · Secondary endpoints revised (3) · 1 morev2 Show 4 more changesShow less
    • Primary endpoint revised
    • Completion date: Mar 1, 2023 to Dec 31, 2025
    • Secondary endpoints revised (3)
    • Study description shortened, about 12 words

    See this version in full on ClinicalTrials.gov ↗

  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Since much is unknown about factors that lead to progression of the pre-neoplastic lesions and cancer. In addition, there is ongoing debate on the optimal surveillance intervals and techniques. To solve these important clinical questions, the establishment of a registry for a longitudinal study is planned.
Trial Details
NCT Number NCT05053945
Lead Sponsor Chinese University of Hong Kong
Conditions Helicobacter Pylori, Atrophic Gastritis, Intestinal Metaplasia
Enrollment 260 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov